Norris Medicines share news and announcements
BSE: 524414Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹15.00.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15 Cr4,400th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 0.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 748
Norris Medicines board meetings
111 filed, newest first. Page 1 of 3.
Sep 2026
Aug 2026
10 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
Jul 2026
May 2026
25 May · Board meeting
Meeting on 30 May 2026: audited results
Feb 2026
11 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Nov 2025
10 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Sep 2025
1 Sep · Board meeting
Aug 2025
11 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
May 2025
28 May · Board meeting
28 May · Board meeting
23 May · Board meeting
Meeting on 28 May 2025: audited results
Feb 2025
10 Feb · Board meeting
Meeting on 13 Feb 2025: quarterly results
Nov 2024
14 Nov · Board meeting
11 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Sep 2024
25 Sep · Board meeting
Meeting on 25 Sep 202425 Sep · Board meeting
Aug 2024
14 Aug · Board meeting
9 Aug · Board meeting
Meeting on 14 Aug 2024: annual general meeting and quarterly results
May 2024
22 May · Board meeting
Meeting on 29 May 2024: audited results and quarterly results
Apr 2024
29 Apr · Board meeting
Meeting on 29 Apr 202429 Apr · Board meeting
Mar 2024
29 Mar · Board meeting
22 Mar · Board meeting
Feb 2024
8 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Dec 2023
29 Dec · Board meeting
22 Dec · Board meeting
Meeting on 29 Dec 2023
Nov 2023
18 Nov · Board meeting
15 Nov · Board meeting
Meeting on 18 Nov 2023: annual general meeting3 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Aug 2023
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
May 2023
18 May · Board meeting
Meeting on 25 May 2023: audited results
Mar 2023
24 Mar · Board meeting